Muhammad Ali Rajput

Dr. Muhammad Ali Rajput


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

3 August 2017 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
MRMuhammad Ali Rajput
Muhammad Ali Rajput
RKRafeeq Alam Khan
Rafeeq Alam Khan
TATahira Assad
Tahira Assad

1 January 2013
Verified
Journal Article
Open access
MRMuhammad Ali Rajput
Muhammad Ali Rajput
RKRafeeq Khan
Rafeeq Khan
ZFZeeshan Feroz
Zeeshan Feroz
This study aims to investigate the effect of a methanol extract of Trachyspermum ammi (L.) as an antiepileptic agent. Tests were conducted with a single- and multiple-dosing schedule of Trachyspermum ammi (L.), using a strychnine-induced seizure model for epilepsy. Twenty-one animals were divided into three groups; control (vehicle), standard (diazepam) and test (Trachyspermum ammi (L.) extract). Trachyspermum ammi (L.) demonstrated antiepileptic effects, since there was a highly significant delay in the onset of convulsions as compared to the control, whereas the percentage of animals that survived or ignored seizure was also greater compared to the control. However, the duration of convulsions was significantly increased with both Trachyspermum ammi (L.) and diazepam as compared to the control. The methanol extract of Trachyspermum ammi (L.) showed antiepileptic activity, which may be due to the presence of thymol

1 June 2020 in Journal of Taibah University Medical Sciences
Verified
Journal Article
Open access
MRMuhammad Ali Rajput
Muhammad Ali Rajput
FAFizzah Ali
Fizzah Ali
TZTabassum Zehra
Tabassum Zehra
SZShahid Zafar
Shahid Zafar
GKGunesh Kumar
Gunesh Kumar
This study aimed to evaluate the effect of proton pump inhibitors on glycaemic control amongst diabetic patients taking anti-diabetic medications. This randomised interventional clinical study was conducted in Basic Medical Sciences Institute, Jinnah Postgraduate Medical Centre, Karachi. Eighty patients of either sex (aged 30–60 years) with type 2 diabetes mellitus and without any known comorbidities were equally divided into two groups (i.e., n = 40 for each group) and were included in this study. Group A received metformin and glimepiride, while Group B, metformin and glimepiride plus omeprazole. The efficacy of the combination medications was evaluated based on fasting blood sugar (FBS) and glycosylated haemoglobin (HbA1c) levels. Serum creatinine and liver function tests were reviewed to evaluate patients' safety profile at the initial visit and after 12 weeks. After 12 weeks of omeprazole therapy, we observed a more significant improvement in glycaemic control in group B compared to group A based on the patients' FBS (108 ± 2.37 vs. 126 ± 2.9, P = 0.001) and HbA1c levels (7.29 ± 0.07 vs. 7.47 ± 0.04, P = 0.030). The addition of a proton pump inhibitor along with anti-diabetic medications was considered effective in achieving better glycaemic control.

21 April 2018 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
TATahira Assad
Tahira Assad
RKRafeeq Khan
Rafeeq Khan
MRMuhammad Ali Rajput
Muhammad Ali Rajput

1 October 2018 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
RKRafeeq Khan
Rafeeq Khan
MRMuhammad Ali Rajput
Muhammad Ali Rajput
TATahira Assad
Tahira Assad